Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (482)	1/2/1998 12:43:00 AM
From: Marshall	Respond to of 834

Probably because he's nervous. Shorting companies that enter into financing deals has been all the rage for some time and I'd bet TXB picked up a few "followers" in the past due to this very reason. Look at Wednesday's intraday as well as a few historical charts. Now I'm no expert on charts but I do know that the activity of most biotech stocks tends to lead events. I'm seeing charts pointing towards something good in the works, not something bad. Were there any problems related to the Novastan trials you can almost bet it would be showing up in those charts long before some internet chat thread "exposed" anything. If I was short the stock I'd be a little nervous too considering the past 10 days' activity. :-)